Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, November 15, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Sean Lee Maintained (CASI) at Strong Buy with Decreased Target to $10 on, Nov 15th, 2022
Sean Lee of HC Wainwright & Co., Maintained "CASI Pharmaceuticals, Inc." (CASI) at Strong Buy with Decreased Target from $12 to $10 on, Nov 15th, 2022.
Sean has made no other calls on CASI in the last 4 months.
There is 1 other peer that has a rating on CASI. Out of the 1 peers that are also analyzing CASI, 0 agree with Sean's Rating of Hold.
This is the rating of the analyst that currently disagrees with Sean
- Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $12 on, Monday, August 15th, 2022
